Sonoma Pharmaceuticals, Inc. (SNOA) Social Stream
SONOMA PHARMACEUTICALS INC (SNOA) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering SONOMA PHARMACEUTICALS INC.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
Price Target Last Issued September 5, 2023
SNOA Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for SNOA as an investment opportunity.
- To contextualize these metrics, consider that out of all US stocks, SONOMA PHARMACEUTICALS INC's number of analysts covering the stock is greater than nearly none of them.
- SNOA has a lower variance in analysts' estimates than nearly 100% of all US stocks.
- SNOA has a higher average analyst price target than 3.22% of Healthcare stocks.
- In the context of Healthcare stocks, SONOMA PHARMACEUTICALS INC's upside potential (average analyst target price relative to current price) is greater than 92.46% of them.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to SONOMA PHARMACEUTICALS INC are OCUP, OGEN, and NBSE.
Make investment decisions regarding SNOA using the data that counts. Try POWR Ratings for free.